Global Market for Elder Care Technology to Reach $13.6 Billion by 2022
October 11, 2018
WELLESLEY, Mass., October 11, 2018 – Due to the emergence of combination healthcare devices and the growing needs of the elder population, the global market for long-term and home healthcare is growing rapidly, according to a new report from BCC Research.
In 2017, the global market for elder care technology was worth $5.6 billion. BCC Research estimates that it will reach a value of $13.6 billion by 2022, indicating a compound annual growth rate of 19.2%, according to the report Technologies for Long Term Health Care and Home Health Care.
In this study, safety monitoring technologies include assist-call devices, medication management products, wander management systems, fall management devices, smart home systems and robotically enhanced mobility assistance devices. These technologies increase, maintain and improve the functional capabilities, independence and safety of seniors.
Research Highlights
- Major companies that are influencing this market include AMC Health, BioTelemetry, Inc., Boston Scientific, Biotronik SE & Co. KG, Bosch Healthcare, Care Innovations, LLC, Honeywell Life Care Solutions, LifeWatch AG, Medtronic Plc., Omron Healthcare, Inc., Philips Healthcare, St. Jude Medical, Inc., VRI, Inc.
- Additional drivers of this market include the growing number of seniors, increasing life-expectancy, skyrocketing healthcare costs, growing shortage of healthcare professionals and caregivers and seniors’ preference to age in place (lead an independent and active life as long as possible.
- Safety monitoring is projected to grow at a higher CAGR (previously forecasted CAGR was a rise of 9.9% vs. 13.2% CAGR rise projected in this report).
“It’s a well-known fact that the global population is aging,” said report author, Shalini Shahani Dewan. “More precisely, there are an increasing number of seniors in the total population. According to the 2017 World Population Data Sheet from the Population Reference Bureau, July 2017, 9% of the world population is aged 65 and above. In more developed parts of the world, the percentage was as high as 18% including 28% in Japan and 15% in the United States.”
Editors/reporters requesting analyst interviews should contact Eric Surber at press@bccresearch.com.
Technologies for Long-term Care and Home Healthcare: Global Markets( HLC079D )
Publish Date: Oct 2018
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
- State of the Life Sciences Industry - 2026 First Quarter Review
- Noninvasive Cancer Diagnostics: Technologies and Global Markets
- Infusion Pumps and Devices: Technologies and Global Markets
- Technologies for Long-Term Care and Home Healthcare: Global Markets
- 3D Protein Structure Analysis: Global Markets
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development